Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Qiming Raises $222 Million in China RMB Venture Fund

publication date: Nov 9, 2016
Qiming Venture Partners has closed its fourth RMB fund at $222 million, which brings its assets-under-management to $2.7 billion. Earlier this year, Qiming closed a US-dollar fund at $650 million, and it now has five US-dollar and four RMB funds. Qiming, which has offices in Shanghai, Beijing, Suzhou and Hong Kong, was formed in 2006. Historically, it has invested about 40% of its capital in life science companies and had, by the beginning of 2017, invested in nearly 50 separate life science companies. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here